These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11707164)

  • 41. Attention deficit/hyperactivity disorder across the lifespan.
    Wilens TE; Biederman J; Spencer TJ
    Annu Rev Med; 2002; 53():113-31. PubMed ID: 11818466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood?
    Volkow ND; Swanson JM
    Am J Psychiatry; 2008 May; 165(5):553-5. PubMed ID: 18450933
    [No Abstract]   [Full Text] [Related]  

  • 43. Relation between childhood disruptive behavior disorders and substance use and dependence symptoms in young adulthood: individuals with symptoms of attention-deficit/hyperactivity disorder and conduct disorder are uniquely at risk.
    Flory K; Milich R; Lynam DR; Leukefeld C; Clayton R
    Psychol Addict Behav; 2003 Jun; 17(2):151-8. PubMed ID: 12814279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adult ADHD and substance abuse: diagnostic and treatment issues.
    Kalbag AS; Levin FR
    Subst Use Misuse; 2005; 40(13-14):1955-81, 2043-8. PubMed ID: 16282088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
    Simon N; Rolland B; Karila L
    Curr Pharm Des; 2015; 21(23):3359-66. PubMed ID: 26088112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relation between attention deficit hyperactivity disorder and substance abuse: what role does conduct disorder play?
    Flory K; Lynam DR
    Clin Child Fam Psychol Rev; 2003 Mar; 6(1):1-16. PubMed ID: 12659448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylphenidate effects on processing speed in a clinical sample of adults with ADHD and substance use disorder: a pilot study.
    Arvidsson M; Dahl ML; Franck J; Wiig EH; Nielsen NP
    Nord J Psychiatry; 2019 Feb; 73(2):118-124. PubMed ID: 30861357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions.
    Fatséas M; Hurmic H; Serre F; Debrabant R; Daulouède JP; Denis C; Auriacombe M
    Psychiatry Res; 2016 Dec; 246():656-662. PubMed ID: 27842945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Attention deficit hyperactivity disorder in adults. An overview].
    Sobanski E; Alm B
    Nervenarzt; 2004 Jul; 75(7):697-715; quiz 716. PubMed ID: 15221066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.
    Wilens TE; Faraone SV; Biederman J; Gunawardene S
    Pediatrics; 2003 Jan; 111(1):179-85. PubMed ID: 12509574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E; Levy S;
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use Motives of Patients with Amphetamine-Type Stimulants Use Disorder and Attention-Deficit/Hyperactivity Disorder.
    Thurn D; Riedner A; Wolstein J
    Eur Addict Res; 2020; 26(4-5):254-262. PubMed ID: 32564027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment strategies for co-occurring ADHD and substance use disorders.
    Mariani JJ; Levin FR
    Am J Addict; 2007; 16 Suppl 1(Suppl 1):45-54; quiz 55-6. PubMed ID: 17453606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adult attention deficit/hyperactivity disorder in the ambulatory care setting.
    Hackett A; Joseph R; Robinson K; Welsh J; Nicholas J; Schmidt E
    JAAPA; 2020 Aug; 33(8):12-16. PubMed ID: 32740107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders.
    Luo SX; Levin FR
    Curr Psychiatry Rep; 2017 Mar; 19(3):14. PubMed ID: 28251590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).
    Kollins SH
    Am J Addict; 2007; 16 Suppl 1():35-42; quiz 43-4. PubMed ID: 17453605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.
    McGough JJ; Smalley SL; McCracken JT; Yang M; Del'Homme M; Lynn DE; Loo S
    Am J Psychiatry; 2005 Sep; 162(9):1621-7. PubMed ID: 16135620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attention-deficit/hyperactivity disorder.
    Shaywitz BA; Fletcher JM; Shaywitz SE
    Adv Pediatr; 1997; 44():331-67. PubMed ID: 9265975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Adult attention deficit/hyperactivity disorder, associated symptoms and comorbid psychiatric disorders: diagnosis and pharmacological treatment].
    Paslakis G; Schredl M; Alm B; Sobanski E
    Fortschr Neurol Psychiatr; 2013 Aug; 81(8):444-51. PubMed ID: 23864520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Assessment of the attention-deficit hyperactivity disorder in adults].
    Gross J; Blocher D; Trott GE; Rösler M
    Nervenarzt; 1999 Jan; 70(1):20-5. PubMed ID: 10087514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.